Brief: China Biotech Services Sees Net Profit Attributable Of Not Less Than Hk$150 MLN For 9M
04/11/2022 14:08
Nov 4 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* SEES NET PROFIT ATTRIBUTABLE OF NOT LESS THAN HK$150
MILLION
FOR 9-MTHS
* EXPECTED RESULT DUE ROBUST DEMANDS FOR RAPID ANTIGEN TEST
KITS
AND COVID-19 TESTING SERVICES, AMONG OTHERS
Source text for Eikon: ID:
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)